21 November 2025
Sidley Represents Nuvalent in Pricing of US$500 Million Public Offering
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Rosemary Reilly Lead | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Craig Hilts Lead | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Torrey Cope | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Kevin Sforza | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Tanner Groce | Sidley | Not stated | Energy and Infrastructure | Not stated |
| Emily Ivers | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Talbott Paulsen | Sidley | Not stated | M&A | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 500m (US$500 million)
- What the figure measures
- Issue size
- Client
- Nuvalent, Inc.Issuer
- Counterparties
- J.P. Morgan (Underwriters)
Jefferies (Underwriters)
TD Cowen (Underwriters)
Cantor (Underwriters)